Defining covariate distribution models for clinical trial simulation

Simulation for Designing Clinical Trials: A Pharmacokinetic-Pharmacodynamic Modeling Perspective

Volumn , Issue , 2002, Pages 31-54

  Mould, Diane R ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b Projections Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889425904     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (24)

1. NHG Holford, M Hale, HC Ko, J-L Steimer, CC Peck. Contributors: P Bonate, WR Gillespie, T Ludden, DB Rubin, LB Sheiner, D Stanski. Simulation in Drugs Development: Good Practices, 1999. http://cdds.georgetown.edu
2. GS May, DL DeMets, LM Friedman, C Furberg, E Passamani. The randomized clinical trial: bias in analysis. Circulation 64(4):669-673, 1981.
3. B Ziegler, H Praehofer, TG Kim. Theory of Modeling and Simulation, 2nd ed. San Diego, CA: Academic Press, 2000, pp 4, 367-389.
4. SL Beal, AJ Boeckmann, LB Sheiner. NONMEM Users Guides, Version V. San Francisco, CA: University of California at San Francisco, NONMEM Project Group, 1999.
5. Pharsight Corporation Trial Simulator, Version 2.0 Users Guide, Mountain View, CA: Pharsight Corporation, 2000.
6. FDA Guidance for Industry Population Pharmacokinetics, 1999. http://www.fda.gov/cber/gdlns/popharm.pdf
7. AC Davison, DV Hinkley. Bootstrap Methods and Their Application (Cambridge Series in Statistical and Probabilistic Mathematics, No. 1). Cambridge, UK: Cambridge University Press, 1997, pp 14-30, 143, 145.
8. A Yafune, M Ishiguro. Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters I: use of a bootstrap standard error. Statistics Med 18:581-599, 1999.
9. SJ Pocock, R Simon. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31(1):103-115, 1975.
10. BJ Anderson, GA Woollard, NH Holford. A model size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol 50(2):125-134, 2000.
11. AM Law, WD Kelton. Simulation Modeling and Analysis, 2nd ed. New York: McGraw-Hill, 1991, pp 335-348, 490-503.
12. GEP Box, ME Muller. A note on the generation of random normal deviates. Ann Math Statist 29:610-611, 1958.
13. G Marsaglia, TA Bray. A convenient method for generating normal variables. SIAM Rev. 6:260-264, 1964.
14. CR Mitchell, As Paulson, CA Beswick. The effect of correlate exponential service times on single tandem queues. Nav Res Logist Quart 24:95-112, 1977.
15. IMSL Users Manual: Stat/Library vol. 3, Houston, TX: IMSL, 1987.
16. ME Johnson. Multivariate Statistical Simulation. New York: John Wiley, 1987.
17. ME Johnson, C Wang, JS Ramberg. Generation of continuous multivariate distributions for statistical applications. Am J Math Management Sci 4:96-119, 1984.
18. MO Karlsson, EN Jonsson, CG Wiltse, JR Wade. Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients. J Pharmacokinet Biopharm 26(2):207-246, 1998.
19. DR Mould, NHG Holford. The pharmacokinetics and pharmacodynamics of topotecan. Proceedings of EORTC/PAMM, Verona, Italy, 2001.
20. SD Ramsey, M McIntoch, R Etzioni, N Urban. Simulation modeling of outcomes and cost effectiveness. Hematol Oncol Clin North Am 14(4):925-938, 2000.
21. D Cloud, L Rainey. Applied Modeling and Simulation: An Integrated Approach to Development and Operation. New York: McGraw-Hill, 1998.
22. Y Yano, SL Beal, LB Sheiner. Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check. J Pharmacokinet Biopharm 28(2):171-192, 2001.
23. JC Kimko, SS Reele, NH Holford, CC Peck. Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model. Clin Pharmacol Ther 68(5):568-577, 2000.
24. LB Sheiner. Learning versus confirming in clinical drug development. Clin Pharmacol Ther 61(3):275-291, 1997.